Arrowhead Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $110.2M | $81.2M |
| FY2016 | — | $95.6M | $85.4M |
| FY2017 | — | $81.4M | $24.8M |
| FY2018 | — | $95.8M | $30.1M |
| FY2019 | — | $244.6M | $221.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $110.2M | $81.2M |
| FY2016 | — | $95.6M | $85.4M |
| FY2017 | — | $81.4M | $24.8M |
| FY2018 | — | $95.8M | $30.1M |
| FY2019 | — | $244.6M | $221.8M |